In the latest trading session, Cathie Wood's ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for ...

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

EST Cathie Wood’s ARK Investment buys 77.6K shares of 10x Genomics (TXG) todayMaximize Your Portfolio with Data Driven Insights:Leverage ...

ARK Invest's 13F portfolio value increased by ~10% to ~$12B this quarter. Check out the top holdings and new stakes of the ...

Cathie Wood says most profound application of AI is in healthcare. She particularly expects Recursion Pharma and Illumina to ...

Cathie Wood, CEO and CIO of Ark Invest, highlighted that one of the dominant themes of 2025 will be ongoing investment in ...

Cathie Wood, the CEO of Ark Investment Management, has made headlines recently with significant trades in the tech sector, ...

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive ...

Cathie Wood, chief of Ark Investment Management, believes in tech stocks that will have a “disruptive” impact in the future. She often trims her stakes to lock up profits. Sometimes, her strategy ...

Cathie Wood-led Ark Invest made significant trades involving CRSP, TXG, RBLX, ACHR, NU, ADYEY, ACCD, and AVAV.

“Lowering costs is great for the world,” Wood said in an interview with Bloomberg TV. “They were collapsing anyway, DeepSeek has stepped it up a notch.

Cathie Wood is one of the most vocal bulls on Wall Street when it comes to the potential of artificial intelligence (AI).